The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.10
Bid: 43.10
Ask: 46.90
Change: 1.30 (2.97%)
Spread: 3.80 (8.817%)
Open: 43.10
High: 43.10
Low: 43.10
Prev. Close: 43.70
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Improve International

23 Jun 2020 07:00

RNS Number : 7670Q
Benchmark Holdings PLC
23 June 2020
 

 

23 June 2020

 

Benchmark Holdings plc

("Benchmark" or the "Company")

 

Sale of Improve International - A significant step in strategic exit of non-core activities

 

Benchmark Holdings plc, the aquaculture genetics, health and specialist nutrition business, is pleased to announce that it has completed the sale of Improve International Limited and its subsidiaries ("Improve"), a global provider of Continuing Professional Development training for veterinary professionals, to RJD Partners and Heber Alves, David Babington, and Rui Lobão (the "Improve Directors") (the "Disposal").

Under the terms of the Disposal the Company will receive a total cash consideration of up to £12.75m, comprising a £9.5m initial payment on completion and deferred consideration of up to £3.25m, payable in three instalments between completion and September 2022, contingent on certain performance conditions being met.

The Disposal is an important step in Benchmark's strategy to exit non-core areas to focus on its key disciplines in the global aquaculture markets, and is part of the Company's programme of disposals which, as stated in our interims results announcement of 29th May, is expected to generate £27m-£30m in total. The proceeds from the Disposal further strengthen the Group's financial position and liquidity.

Improve is held as a discontinued operation in Benchmark's 2019 audited accounts and 2020 unaudited interim accounts and generated revenues and adjusted EBITDA of £10.1m and £1.7m respectively in the twelve months ended 31 March 2020.

The Improve Directors, who are also employees of Improve, will participate in the acquisition of Improve and have a resulting interest in up to 30% of the share capital in Improve. As such, the Disposal constitutes a related party transaction under the AIM Rules. The Directors of the Company consider, having consulted with Numis, acting in its capacity as the Company's Nominated Adviser, that the terms of the Disposal are fair and reasonable insofar as the Company's shareholders are concerned.

Trond Williksen, CEO, commented:

"The disposal of Improve marks a significant milestone in our programme of disposals and restructuring, which remains a key priority as we seek to re-focus the business on our core aquaculture disciplines and transition from R&D investment into profitability."

Enquiries

 

For further information, please contact:

Benchmark Holdings plc

Tel: 020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

 

MHP Communications

 

Tel: 020 3128 8742

Katie Hunt, Reg Hoare, Alistair de Kare-Silver benchmark@mphc.com

 

 

About Benchmark 

Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISFZGZVKFRGGZG
Date   Source Headline
12th Oct 20202:50 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Sep 20205:58 pmRNSHolding(s) in Company
10th Sep 20209:15 amRNSPositive Opinion from the EMA on BMK08
4th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSQ3 Results
21st Aug 20207:00 amRNSNotice of Q3 Results
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility
31st Jul 20207:00 amRNSTotal Voting Rights
23rd Jul 202011:05 amRNSSale of vaccine manufacturing assets
1st Jul 20207:00 amRNSSale of FishVet
30th Jun 20207:00 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSSale of Improve International
8th Jun 20204:54 pmRNSDirector/PDMR Shareholding - Replacement
8th Jun 202010:43 amRNSDirector/PDMR Shareholding
5th Jun 20205:50 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSSecond Quarter and Interim Results
27th May 20208:30 amRNSEquity Development Results Webinar
19th May 20207:00 amRNSNotice of Q2 and Interim Results
6th May 202012:09 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights
21st Apr 20207:00 amRNSDirector and Divisional Management Changes
7th Apr 20207:00 amRNSAppointment of Chief Executive Officer
2nd Apr 20207:00 amRNSCovid-19 update
31st Mar 202011:12 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSBlock Listing Six Monthly Review
18th Mar 20207:00 amRNSBlock Admission Application
16th Mar 202012:00 pmRNSDirector Dealings
12th Mar 20201:15 pmRNSResult of AGM
9th Mar 20202:01 pmRNSHolding(s) in Company
9th Mar 20201:46 pmRNSDIRECTOR DEALINGS
28th Feb 20207:00 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSQ1 Results
25th Feb 20209:43 amRNSDIRECTOR SHARE OPTIONS
21st Feb 202010:49 amRNSDirector/PDMR Shareholding
20th Feb 20204:10 pmRNSHolding(s) in Company
20th Feb 20209:15 amRNSHolding(s) in Company
17th Feb 20204:28 pmRNSResult of General Meeting and Total Voting Rights
17th Feb 20207:00 amRNSResult of Open Offer
11th Feb 20207:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
31st Jan 20207:00 amRNSTotal Voting Rights
30th Jan 20202:46 pmRNSTimetable for Placing and Open Offer
30th Jan 20207:00 amRNSPlacing and Open Offer
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20199:06 amRNSSecond Price Monitoring Extn
20th Dec 20199:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.